Table 2. Main outcomes.
Placebo (65) |
HCQ (62) |
Crude Hazard ratio (HR) |
Adjusted HR |
|
---|---|---|---|---|
Symptomatic COVID-19 infection | 6/65 (9.2%) |
1/62 (1.6%) |
0.18 (0.02–1.48) | 0.18 (0.21–1.59) |
Adverse events | 38/65 (58.5%) |
32/62 (51.6%) |
0.98 (0.94–1.03) | 0.78 (0.38–1.59) |